How Affordable are Targeted Therapies in Non-Small Cell Lung Cancer?

ISSN： 1527-2729

Source： Current Treatment Options in Oncology, Vol.12, Iss.1, 2011-03, pp. : 1-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNAs and Targeted Therapies in Non-small Cell Lung Cancer: Minireview

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 6, 2015-07 ,pp. : 694-700

Bentham Science Publishers

Access to resources Recommend Favorite

Insights into Angiogenesis in Non-Small Cell Lung Cancer: Molecular Mechanisms, Polymorphic Genes, and Targeted Therapies

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 1, 2012-01 ,pp. : 118-131

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted therapies in small cell lung cancer (Review)

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 3-11

Spandidos Publications

Access to resources Recommend Favorite

From targets to targeted therapies and molecular profiling in non-small cell lung carcinoma

By Thomas A. Rajan A. Lopez-Chavez A. Wang Y. Giaccone G.

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 577-585

Oxford University Press

Access to resources Recommend Favorite

Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe

By Schiller J. Tilden D. Aristides M. Lees M. Kielhorn A. Maniadakis N. Bhalla S.

Lung Cancer, Vol. 43, Iss. 1, 2004-01 ,pp. : 101-112

Elsevier

Access to resources Recommend Favorite